6533b860fe1ef96bd12c2f7d
RESEARCH PRODUCT
Response to "The combination therapy with cytapheresis plus vedolizumab in a corticosteroid-dependent patient with ulcerative colitis and previous Anti-TNF alfa failure".
Maria CappelloAlessandro VitelloB. Scrivosubject
medicine.medical_specialtyCombination therapymedicine.drug_class030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedGastroenterologyVedolizumab03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicinemedicineHumansColitisHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologymedicine.diseaseUlcerative colitisCytapheresisMonoclonalCorticosteroidTumor necrosis factor alphaColitis UlcerativebusinessCytapheresis030215 immunologymedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver |